The first-ever implantable continuous glucose monitoring system has been approved by the U.S. Food and Drug Administration (FDA). The Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes will include a fully implantable sensor to detect glucose. It can be worn for up to 90 days.… Continue reading FDA Approves Implantable Continuous Glucose Monitoring System